These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 30099750)
41. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. Bogdanos DP; Pares A; Baum H; Caballeria L; Rigopoulou EI; Ma Y; Burroughs AK; Rodes J; Vergani D J Autoimmun; 2004 Jun; 22(4):353-62. PubMed ID: 15120760 [TBL] [Abstract][Full Text] [Related]
42. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637 [TBL] [Abstract][Full Text] [Related]
43. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422 [TBL] [Abstract][Full Text] [Related]
44. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455 [TBL] [Abstract][Full Text] [Related]
45. The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Bogdanos DP; Baum H; Vergani D; Burroughs AK Dis Markers; 2010; 29(6):301-11. PubMed ID: 21297249 [TBL] [Abstract][Full Text] [Related]
46. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Smyk DS; Bogdanos DP; Kriese S; Billinis C; Burroughs AK; Rigopoulou EI Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):110-21. PubMed ID: 21907008 [TBL] [Abstract][Full Text] [Related]
47. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis. Bassendine MF; Jones DE; Yeaman SJ Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910 [TBL] [Abstract][Full Text] [Related]
48. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Leung PS; Rossaro L; Davis PA; Park O; Tanaka A; Kikuchi K; Miyakawa H; Norman GL; Lee W; Gershwin ME; Hepatology; 2007 Nov; 46(5):1436-42. PubMed ID: 17657817 [TBL] [Abstract][Full Text] [Related]
49. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. Tanimoto H; Shimoda S; Nakamura M; Ishibashi H; Kawano A; Kamihira T; Matsushita S; Gershwin ME; Harada M J Autoimmun; 2003 May; 20(3):255-63. PubMed ID: 12753811 [TBL] [Abstract][Full Text] [Related]
51. TCRβ repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis. Hou X; Yang Y; Chen J; Jia H; Zeng P; Lv L; Lu Y; Liu X; Diao H Liver Int; 2019 May; 39(5):956-966. PubMed ID: 30721553 [TBL] [Abstract][Full Text] [Related]
52. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Gershwin ME; Rowley M; Davis PA; Leung P; Coppel R; Mackay IR Prog Liver Dis; 1992; 10():47-61. PubMed ID: 1296237 [TBL] [Abstract][Full Text] [Related]
53. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028 [TBL] [Abstract][Full Text] [Related]
54. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607 [TBL] [Abstract][Full Text] [Related]
55. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Shimoda S; Nakamura M; Ishibashi H; Kawano A; Kamihira T; Sakamoto N; Matsushita S; Tanaka A; Worman HJ; Gershwin ME; Harada M Gastroenterology; 2003 Jun; 124(7):1915-25. PubMed ID: 12806624 [TBL] [Abstract][Full Text] [Related]
56. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Leung PS; Lam K; Kurth MJ; Coppel RL; Gershwin ME Trends Mol Med; 2012 Oct; 18(10):577-82. PubMed ID: 22920894 [TBL] [Abstract][Full Text] [Related]
57. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis. Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430 [TBL] [Abstract][Full Text] [Related]
59. [Association between chronic urinary tract infection and primary biliary cirrhosis]. Xu Y; Wang JB; Wang S Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):478-80. PubMed ID: 27465958 [TBL] [Abstract][Full Text] [Related]
60. Evolution of our understanding of PBC. Tanaka A; Leung PSC; Gershwin ME Best Pract Res Clin Gastroenterol; 2018; 34-35():3-9. PubMed ID: 30343708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]